Saturday 7 November 2026 Export GERN’s income statement to Excel — free account

Geron Corporation

GERN Healthcare Biotechnology

Geron Corporation’s revenue for fiscal 2025 (year ended December 2025) was $183.9 million, up 138.8% from fiscal 2024.

Revenue: +27.5%
EPS: +106.7%
Free cash flow: +176.1%
Total debt: +0.99%

Quarter to September 2026, against a year earlier

0.98 0.03 +3.16%

Follow GERN

Alert me

Market cap: $610.4M
P/E: 0.0×
Fwd P/E: −20.3×
Dividend yield: —
F-score: 3/9
Altman Z: −2.24
Beneish M: −1.70
Dividend safety: n/a

Overview

	Sep '26	Jun '26	Mar '26	Dec '25	Older periods
P/E ratio Full definition →	0.00	0.00	0.00	0.00	+8 more quarters Free account
P/S ratio Full definition →	3.80	4.20	5.09	4.79
P/FCF ratio Full definition →	0.00	0.00	0.00	0.00
P/Operating CF Full definition →	80.54	(54.24)	(15.85)	(39.88)
P/B ratio Full definition →	3.65	3.93	4.35	3.90
Price to Tangible BV Full definition →	3.65	3.93	4.35	3.90
EV/Sales Full definition →	3.36	3.65	4.46	3.87
EV/EBITDA Full definition →	0.00	0.00	0.00	0.00
EV/Operating CF Full definition →	(8.07)	(6.53)	(6.94)	(6.41)
EV/FCF Full definition →	(8.01)	(6.51)	(6.92)	(6.40)
Quick Ratio Full definition →	4.53	5.07	4.87	3.58
Current Ratio Full definition →	6.31	6.92	6.78	4.66
Net Debt/EBITDA Full definition →	(28.16)	14.52	650.34	9.09
Debt/Assets Full definition →	22.85%	23.15%	22.44%	20.95%
Debt/Equity Full definition →	0.53	0.55	0.52	0.53
Asset Turnover Full definition →	0.40	0.38	0.36	0.32
Operating CF/Net income Full definition →	7.61	0.95	17.27	0.76
Capex/Depreciation Full definition →	(0.94)	2.86	0.55	0.00
Interest Coverage Full definition →	0.80	(1.75)	0.02	(3.50)
Research and Development Expense of Revenue Full definition →	21.11%	38.33%	28.85%	28.22%
Selling, General and Administrative Expense of Revenue Full definition →	59.32%	67.61%	68.34%	86.78%
Intangible Assets out of Total Assets Full definition →	0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →	8.00%	8.61%	9.48%	12.06%
Graham Net Nets Full definition →	0.20	0.22	0.19	0.20
Graham Number Full definition →	0.00	0.00	0.00	0.00
Earnings Yield Full definition →	(5.97%)	(8.23%)	(7.07%)	(9.85%)
Free Cash Flow Yield Full definition →	(11.02%)	(13.37%)	(12.66%)	(12.62%)
Revenue per Share Full definition →	0.09	0.09	0.08	0.07
Operating CF per Share Full definition →	0.02	(0.02)	(0.09)	(0.03)
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →	0.02	(0.02)	(0.09)	(0.03)
Cash per Share Full definition →	0.43	0.45	0.47	0.54
Shareholders Equity per Share Full definition →	0.34	0.33	0.34	0.34
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	0.34	0.33	0.34	0.34
Free Cash Flow Full definition →	10.11	(16.05)	(63.16)	(22.07)
Working Capital Full definition →	394.49	416.01	424.96	408.73
Capital Expenditures Full definition →	(0.15)	(0.22)	(0.25)	0.00
Net Current Asset Value Full definition →	168.33	185.94	193.52	175.60
EV/EBIT Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	0.00	0.00	0.00	0.00
Price to Operating Income Full definition →	0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →	42.83	46.43	39.04	39.01
Average Payables Full definition →	13.29	8.52	10.38	9.93
Average Inventory Full definition →	111.01	96.36	94.75	77.68
Average Assets Full definition →	547.24	537.10	548.29	582.16
Average Common Equity Full definition →	237.70	239.07	248.67	253.10

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026

Stockrow Weekly